Takeda Pharmaceutical Company Limited (TAK)
Health Care
TAK is listed on the New York Stock Exchange, where its shares have traded since March 7, 2008. It represents shares of Takeda Pharmaceutical Company Limited, which reports its financial results in JPY. SentiSense covers it in the Health Care sector.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Latest reported results
Takeda Pharmaceutical Company Limited reported revenue of 1.22 trillion JPY for Q1 FY2026, up 10.2% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 370 institutions reported holding TAK, with 104.0 million shares worth $1.7 billion in aggregate. The largest reported holders were Capital Group, FMR and Morgan Stanley. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on TAK
- TAK sentiment: whether news and social coverage of Takeda Pharmaceutical Company Limited leans bullish or bearish, and the stories driving it.
- TAK ownership: all 370 reporting institutions, plus insider and congressional trades.
- TAK financials: revenue, net income, operating margin and free cash flow through Q1 FY2026.
SentiSense also tracks daily options readings for Takeda Pharmaceutical Company Limited: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Takeda Pharmaceutical Company Limited do?
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025.
What sector is TAK in?
SentiSense classifies Takeda Pharmaceutical Company Limited in the Health Care sector.
Where does TAK stock trade?
TAK is listed on the New York Stock Exchange, where its shares have traded since March 7, 2008. It represents shares of Takeda Pharmaceutical Company Limited, which reports its financial results in JPY.
How many institutions own TAK?
370 institutions reported a position in TAK in 13F filings for the quarter ended June 30, 2026, worth $1.7 billion in total.